Dextech Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-4.96	-4.84	-4.71	-4.59	-5.27	-6.08
Depreciation & Amortization	0.35	0.15	0.15	0.17	0.24	0.27
Other Amortization	4.07	4.07	3.53	2.88	2.79	3.86
Other Operating Activities	0.58	-	-	0.02	-	-
Change in Accounts Receivable	0.16	0.16	-0.05	-0.03	-0.25	-0.02
Change in Other Net Operating Assets	-0.64	-0.64	0.26	0.01	0.49	-0.03
Operating Cash Flow	-0.45	-1.11	-0.81	-1.55	-2	-2
Sale (Purchase) of Intangibles	-3.22	-3.22	-5.39	-8.71	-3.12	-0.63
Investing Cash Flow	-3.47	-3.22	-5.39	-8.71	-3.12	-0.63
Issuance of Common Stock	-	-	-	0.03	46.35	-
Other Financing Activities	-	-	-	-	-9.22	-
Financing Cash Flow	-	-	-	0.03	37.13	-
Net Cash Flow	-3.92	-4.33	-6.19	-10.24	32.02	-2.63
Cash Interest Paid	0	0	-	-	-	0
Levered Free Cash Flow	-2.42	-2.81	-4.96	-8.78	-3.14	-0.36
Unlevered Free Cash Flow	-2.42	-2.81	-4.96	-8.78	-3.14	-0.36
Change in Working Capital	-0.48	-0.48	0.21	-0.03	0.24	-0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.